We are hiring in the Naples and Fort Myers, Florida area. At Florida Oncology & Hematology, we are committed to providing high-quality care that prioritizes both medical excellence and compassionate support for our patients and their families. Check out AON careers > https://hubs.li/Q02GGp4B0 #WeAreAON #Hiring
American Oncology Network’s Post
More Relevant Posts
-
FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023 #CancerTreatment #ClinicalTrialData #DrugApproval #FDAOncology #Healthcare #MedicalResearch #OncoDaily #Oncology
-
Medical Imaging Technologies for Oncology Diagnostics Market Opportunity Analysis Report 2024: Regional Markets and Segments https://lnkd.in/gmKv9EMK #marketanalysis #marketresearch #marketresearchreports #businessintelligence
-
Vice President- Partner Development, Institutional Development and Workforce Initiatives
Focusing on the KPIs That Matter: Tips and tricks for selecting and influencing the factors that will drive your practice to provide higher quality care As business administrators working in hematology/oncology, our mission should always be to provide the highest quality care to as many patients as possible. While this is a lofty goal that can be subjective in some ways, there are objective measures and tactics that can be tied to assessing success. Read the full article here! Read the latest Practice Management Institute / The Michigan Society of Hematology and Oncology article in the August issue of Oncology Practice Management magazine, written by Jason Lockard, MBA, Director, Operations - Pediatric Specialty Corewell Health Medical Group East- great article, Jason!
Focusing on the KPIs That Matter - Oncology Practice Management
oncpracticemanagement.com
-
As we near the end of 2023, the FDA has approved a total of 56 novel drugs this year! If you're curious about the overview, let me know and I'll send it your way. #FDA #noveldrugs #drugapprovals
Many Novel Drug Approvals in 2023! As approach the end of 2023, we have taken a look at the Novel Drug Approvals in 2023 by the FDA. In total, the FDA approved 56 novel drugs. Most NDA's have been for Oncology indications (31%), followed by Neurology and Auto-Immune Indications (11%), Infectious Diseases and Metabolic Disorders (9%) and Ophthalmology Indications (5%). Should you want to receive the full Excel overview for better quality, please reply to this post.
-
-
#Tagraxofusp: the first #CD123-targetedagent in oncology and the first grug specifically approved for #blasticplasmacytoiddendriticcellneoplasm. Read the new review on its development, key preclinical insights, clinical data, and its unique toxicity, the capillary leak syndrome. https://lnkd.in/dsjNx6X3
-
-
How the Patient Perspective Can Drive Powerful Clinical Study Designs in Oncology: Due to their electronic format, ePRO technology offers several benefits to clinical trial sponsors as well, including improved data quality ...
How the Patient Perspective Can Drive Powerful Clinical Study Designs in Oncology - MedCity News
-
Approaching Ethical Dilemmas in Oncology Pharmacy: Karen Fancher, PharmD, BCOP, discusses some guiding principles for oncology pharmacists when facing ethical dilemmas and provides some recommendations for navigating those challenges. #finance #pharmacy #lifesciences
Approaching Ethical Dilemmas in Oncology Pharmacy
-
Don’t miss the latest edition of Oncology Practice Management from the Practice Management Institute, featuring an insightful article by MSHO member Jason Lockard, MBA. Jason shares valuable tips and strategies for selecting and influencing key factors that can elevate the quality of care in your practice. #MSHO24
Vice President- Partner Development, Institutional Development and Workforce Initiatives
Focusing on the KPIs That Matter: Tips and tricks for selecting and influencing the factors that will drive your practice to provide higher quality care As business administrators working in hematology/oncology, our mission should always be to provide the highest quality care to as many patients as possible. While this is a lofty goal that can be subjective in some ways, there are objective measures and tactics that can be tied to assessing success. Read the full article here! Read the latest Practice Management Institute / The Michigan Society of Hematology and Oncology article in the August issue of Oncology Practice Management magazine, written by Jason Lockard, MBA, Director, Operations - Pediatric Specialty Corewell Health Medical Group East- great article, Jason!
Focusing on the KPIs That Matter - Oncology Practice Management
oncpracticemanagement.com
-
Research Scientist I Translational research I Science Communicator I Mentor I Blogger I Forever student of Science & Life
Exciting news on 2023 drug approvals! In 2023, the FDA approved 55 new drugs, with oncology leading the way at 13 approvals, followed by neurology with 9 new drugs. For more details, check out the comprehensive article in Nature. https://lnkd.in/ez7kvamw #FDAApprovals #MedicalInnovation #oncology #drugapproval
-
